Imaging Biomarkers in Thoracic Oncology: Current Advances in the Use of Radiomics in Lung Cancer Patients and its Potential Use for Therapy Response Prediction and Monitoring.
Jonas KroschkeOyunbileg von StackelbergClaus Peter HeußelMark Oliver WielpützHans-Ulrich KauczorPublished in: RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin (2022)
· Kroschke J, von Stackelberg O, Heußel CP et al. Imaging Biomarkers in Thoracic Oncology: Current Advances in the Use of Radiomics in Lung Cancer Patients and its Potential Use for Therapy Response Prediction and Monitoring. Fortschr Röntgenstr 2022; 194: 720 - 727.
Keyphrases
- end stage renal disease
- high resolution
- palliative care
- spinal cord
- chronic kidney disease
- ejection fraction
- newly diagnosed
- lymph node metastasis
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- stem cells
- magnetic resonance imaging
- contrast enhanced
- patient reported outcomes
- mass spectrometry
- cell therapy
- spinal cord injury
- bone marrow
- patient reported